Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

... And Another Makes Stem Cells Regenerate Cartilage

Stem cells mend cartilage, thanks to small molecule

by Sarah Everts
April 9, 2012 | A version of this story appeared in Volume 90, Issue 15

People whose joint cartilage is destroyed by an overactive immune system—a disease called osteoarthritis—can currently choose between painkillers and surgery as treatment options. Drug developers, who have primarily been working to find compounds that stop cartilage destruction, may now wish to focus on a strategy that pushes stem cells to produce more cartilage cells. Researchers led by Peter G. Schultz, at Scripps Research Institute, and Kristen Johnson, at the Genomics Institute of the Novartis Research Foundation, have found a small molecule called kartogenin, which causes mesenchymal stem cells found in joints to differentiate into chondrocyte cells that can build cartilage where it has been destroyed (Science, DOI: 10.1126/science.1215157). The team tested the molecule in rodent arthritis models and found that cartilage repair was induced without any negative side effects. Working out the biochemistry of kartogenin’s mode of action, the team learned that the molecule binds to a protein called filamin A, thereby blocking its interaction with a transcription factor called CBFβ and leading to the production of new chondrocyte cells.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.